Table 1 Demographic and clinical characteristics of the 9 patients
Case | Age (years) | Time to onset after Tusanqi intake (m) | Bilirubin (μmol/L) | ALT (U/L) | PT seconds over control | Albumin (g/L) | CR (μmol/L) | Ascites (grade) | HE | Child Pugh score | MELD score |
|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 50 | 5 | 37.1 | 149 | 6.2 | 29.6 | 61.7 | +++ | 0 | 11 | 17 |
2 | 66 | 24 | 28.7 | 43 | 0 | 29.0 | 116.0 | +++ | 0 | 8 | 13 |
3 | 78 | 3 | 75.8 | 41 | 11.3 | 29.9 | 127.0 | +++ | I | 13 | 26 |
4 | 55 | 1 | 92.4 | 64 | 5.9 | 25.1 | 130.0 | +++ | 0 | 12 | 24 |
5 | 58 | 1.5 | 73.6 | 98 | 1.6 | 32.6 | 85.2 | +++ | 0 | 10 | 16 |
6 | 54 | 6 | 87.7 | 615 | 7.3 | 32.8 | 103.0 | +++ | 0 | 12 | 23 |
7 | 49 | 6 | 38.0 | 27 | 3.8 | 30.2 | 70.2 | +++ | 0 | 9 | 17 |
8 | 66 | 5 | 66.3 | 27 | 0 | 26.2 | 107.0 | +++ | 0 | 11 | 16 |
9 | 62 | 10 | 24.5 | 133 | 0 | 26.0 | 120.0 | +++ | 0 | 9 | 17 |